Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Land

Showing results (121-130 of 142) with videos related to

Pageof 15
Sort By:
Chest|December 1, 2020
Tobacco Treatment Program Models in US Hospitals and Outpatient Centers on Behalf of the SRNT Treatment NetworkAmanda M Palmer, Alana M Rojewski, Li-Shiun Chen, et al.
JAMA|June 7, 2006
Patient-reported symptoms and quality of life during treatment with tamoxifen or raloxifene for breast cancer prevention: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trialStephanie R Land, D Lawrence Wickerham, Joseph P Costantino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2012
Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24D Craig Allred, Stewart J Anderson, Soonmyung Paik, et al.
Journal of Surgical Oncology|July 22, 2010
Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissectionTakamaru Ashikaga, David N Krag, Stephanie R Land, et al.
Tobacco Control|November 17, 2020
Transitions between cigarette, ENDS and dual use in adults in the PATH study (waves 1-4): multistate transition modelling accounting for complex survey designAndrew F Brouwer, Jihyoun Jeon, Jana L Hirschtick, et al.
Cancer Causes & Control : CCC|September 15, 2023
Equitable implementation of lung cancer screening: avoiding its potential to mirror existing inequities among people who use tobaccoEmily Bilenduke, Shacoria Anderson, Alison Brenner, et al.
Chest|March 17, 2023
The Optimizing Lung Screening Trial (WF-20817CD): Multicenter Randomized Effectiveness Implementation Trial to Increase Tobacco Use Cessation for Individuals Undergoing Lung ScreeningKristie L Foley, Emily V Dressler, Kathryn E Weaver, et al.
Preventive Medicine|August 6, 2021
Latent class analysis of use frequencies for multiple tobacco products in US adultsRitesh Mistry, Irina Bondarenko, Jihyoun Jeon, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 8, 2025
The International Association for the Study of Lung Cancer Staging Project: The Impact of Smoking Status on Lung Cancer Staging in the Ninth Edition of the TNM ClassificationLawson Eng, William K Evans, Megan Eisele, et al.
Cancer|March 29, 2016
Cognitive testing of tobacco use items for administration to patients with cancer and cancer survivors in clinical researchStephanie R Land, Graham W Warren, Jennifer L Crafts, et al.
Pageof 15

Showing results (121-130 of 142) with videos related to

Sort By:
Pageof 15
Chest|December 1, 2020
Tobacco Treatment Program Models in US Hospitals and Outpatient Centers on Behalf of the SRNT Treatment NetworkAmanda M Palmer, Alana M Rojewski, Li-Shiun Chen, et al.
JAMA|June 7, 2006
Patient-reported symptoms and quality of life during treatment with tamoxifen or raloxifene for breast cancer prevention: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trialStephanie R Land, D Lawrence Wickerham, Joseph P Costantino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2012
Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24D Craig Allred, Stewart J Anderson, Soonmyung Paik, et al.
Journal of Surgical Oncology|July 22, 2010
Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissectionTakamaru Ashikaga, David N Krag, Stephanie R Land, et al.
Tobacco Control|November 17, 2020
Transitions between cigarette, ENDS and dual use in adults in the PATH study (waves 1-4): multistate transition modelling accounting for complex survey designAndrew F Brouwer, Jihyoun Jeon, Jana L Hirschtick, et al.
Cancer Causes & Control : CCC|September 15, 2023
Equitable implementation of lung cancer screening: avoiding its potential to mirror existing inequities among people who use tobaccoEmily Bilenduke, Shacoria Anderson, Alison Brenner, et al.
Chest|March 17, 2023
The Optimizing Lung Screening Trial (WF-20817CD): Multicenter Randomized Effectiveness Implementation Trial to Increase Tobacco Use Cessation for Individuals Undergoing Lung ScreeningKristie L Foley, Emily V Dressler, Kathryn E Weaver, et al.
Preventive Medicine|August 6, 2021
Latent class analysis of use frequencies for multiple tobacco products in US adultsRitesh Mistry, Irina Bondarenko, Jihyoun Jeon, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 8, 2025
The International Association for the Study of Lung Cancer Staging Project: The Impact of Smoking Status on Lung Cancer Staging in the Ninth Edition of the TNM ClassificationLawson Eng, William K Evans, Megan Eisele, et al.
Cancer|March 29, 2016
Cognitive testing of tobacco use items for administration to patients with cancer and cancer survivors in clinical researchStephanie R Land, Graham W Warren, Jennifer L Crafts, et al.
Pageof 15